Biotech and pharma: a remedy for turbulent times?
In the decade since the financial crisis, pharmaceuticals, healthcare and bioscience-focused funds have significantly outperformed the MSCI World index.
Latest news
-
-
Blackrock undercuts Vanguard with slashed fees
Blackrock has undercut Vanguard by slashing fees on an iShares emerging markets product and matching its rival’s pricing on four European equity funds.
-
Selectors missed US equities opportunity amid volatility
European fund selectors have been overwhelmingly bullish on absolute return strategy funds as a response to market volatility – but they could have made more returns if they took the risky option of US equities.
-
ECB rate rise unlikely before 2020, says Franklin Templeton
Slowing growth, low inflation and political risk in Italy suggest ECB will extend its asset-buying programme into 2019 and as a result push rate hikes further into the future, says asset manager.
-
RM Funds offers ‘highly defensive’ fund
VT RM Alternative Income Fund seeks best-possible returns in worsening economic environment and rising market volatility and will invest in securities across specialist real estate, alternative lending and infrastructure.
-
China A-shares inclusion set to light ESG fuse
The opening of the China A-shares market to foreign investors provides a window for China-focused funds to push ESG criteria into greater prominence in the world’s second largest economy.
-
ESG: ‘Samsung has terrible governance – we wouldn’t go near it’
Panellists at Expert Investor’s Frankfurt Emerging Markets event debated the challenges for investors seeking attractive emerging market investments combined with solid ESG credentials.
-
Politics and inflation fears wipe out 2018 European equity returns
European equity funds have lost all of their gains since the beginning of the year as inflation fears and political uncertainty have dominated headlines with the sector average returning virtually 0% over the first five months.
-
Eurozone volatility could boost appeal of UK stocks
British equities may benefit from political turmoil in Spain and Italy despite Brexit concerns.
-
Aberdeen Standard offers China onshore bond fund
The Ucits fund will seek to invest in liquid government securities and investment grade corporate bonds in the mainland Chinese bond market issued in renminbi.
-
Finding value in EMD and alternative fixed income
To navigate the hazards of the bond markets, one fund manager looks to US and emerging market debt for value while a fund selector finds opportunity in alternative fixed income.
-
The art of disruptive investing
The CPR Invest Global Disruptive Opportunities fund seeks out industry-changing technologies. But how does it avoid the hype and minimise risk to try and make the right predictions?